These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28779354)

  • 41. Use of surgical procedures and adjuvant therapy in rectal cancer treatment: a population-based study.
    Schroen AT; Cress RD
    Ann Surg; 2001 Nov; 234(5):641-51. PubMed ID: 11685027
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Laparoscopic colectomy for cancer: Improved compliance with guidelines for chemotherapy and survival.
    Kim RH; Kavanaugh MM; Caldito GC
    Surgery; 2017 Jun; 161(6):1633-1641. PubMed ID: 28027818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An evaluation of treatment decisions at a colorectal cancer multi-disciplinary team.
    Wood JJ; Metcalfe C; Paes A; Sylvester P; Durdey P; Thomas MG; Blazeby JM
    Colorectal Dis; 2008 Oct; 10(8):769-72. PubMed ID: 18215197
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
    Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of a dedicated multidisciplinary team on the management of early rectal cancer.
    Vaughan-Shaw PG; Wheeler JM; Borley NR
    Colorectal Dis; 2015 Aug; 17(8):704-9. PubMed ID: 25704245
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Active involvement of patients, radiation oncologists, and surgeons in a multidisciplinary team approach: Guiding local therapy in recurrent, metastatic rectal cancer.
    Choi SH; Yang G; Koom WS; Yang SY; Kim SS; Lim JS; Kim HS; Shin SJ; Chang JS
    Cancer Med; 2023 Nov; 12(22):21057-21067. PubMed ID: 37909227
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival outcome of local excision versus radical resection of colon or rectal carcinoma: a Surveillance, Epidemiology, and End Results (SEER) population-based study.
    Bhangu A; Brown G; Nicholls RJ; Wong J; Darzi A; Tekkis P
    Ann Surg; 2013 Oct; 258(4):563-9; discussion 569-71. PubMed ID: 23979270
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prospective controlled study on the usefulness of Carmofur as a postoperative adjuvant chemotherapy for colorectal cancer].
    Yasutomi M; Takahashi T; Kodaira S; Hojo K; Kato T; Ogawa M; Ichihashi H; Tominaga T; Tamada R; Kunii Y; Kikuchi K
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1953-60. PubMed ID: 9350242
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical Significance of Para-Aortic Lymph Node Dissection for Advanced or Metastatic Colorectal Cancer in the Current Era of Modern Chemotherapy.
    Arimoto A; Uehara K; Kato T; Nakamura H; Kamiya T; Nagino M
    Dig Surg; 2015; 32(6):439-44. PubMed ID: 26402333
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does a rectal cancer of the upper third behave more like a colon or a rectal cancer?
    Rosenberg R; Maak M; Schuster T; Becker K; Friess H; Gertler R
    Dis Colon Rectum; 2010 May; 53(5):761-70. PubMed ID: 20389210
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years.
    Sadahiro S; Suzuki T; Ishikawa K; Nakamura T; Tanaka Y; Masuda T; Mukoyama S; Yasuda S; Tajima T; Makuuchi H; Murayama C
    Hepatogastroenterology; 2003; 50(53):1362-6. PubMed ID: 14571738
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 through 2011.
    Zhao H; Zhang N; Ho V; Ding M; He W; Niu J; Yang M; Du XL; Zorzi D; Chavez-MacGregor M; Giordano SH
    Cancer; 2018 Feb; 124(4):679-687. PubMed ID: 29140558
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
    Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
    Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial.
    Li Q; Luo D; Zhu J; Yang L; Liu Q; Ma Y; Liang L; Cai S; Zhang Z; Li X;
    BMC Cancer; 2019 Nov; 19(1):1117. PubMed ID: 31729964
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Adjuvant and perioperative neoadjuvant therapy for colorectal cancer].
    Liu FQ; Cai SJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):315-320. PubMed ID: 31054544
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Benchmarking circumferential resection margin (R1) resection rate for rectal cancer in the neoadjuvant era.
    Chambers W; Collins G; Warren B; Cunningham C; Mortensen N; Lindsey I
    Colorectal Dis; 2010 Sep; 12(9):909-13. PubMed ID: 19508531
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of guideline-recommended adjuvant therapies and survival outcomes for people with colorectal cancer at tertiary referral hospitals in South Australia.
    Adelson P; Fusco K; Karapetis C; Wattchow D; Joshi R; Price T; Sharplin G; Roder D
    J Eval Clin Pract; 2018 Feb; 24(1):135-144. PubMed ID: 28474459
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.
    Bahadoer RR; Dijkstra EA; van Etten B; Marijnen CAM; Putter H; Kranenbarg EM; Roodvoets AGH; Nagtegaal ID; Beets-Tan RGH; Blomqvist LK; Fokstuen T; Ten Tije AJ; Capdevila J; Hendriks MP; Edhemovic I; Cervantes A; Nilsson PJ; Glimelius B; van de Velde CJH; Hospers GAP;
    Lancet Oncol; 2021 Jan; 22(1):29-42. PubMed ID: 33301740
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic factors for survival in stage IV rectal cancer: A Swedish nationwide case-control study.
    Afshari K; Chabok A; Naredi P; Smedh K; Nikberg M
    Surg Oncol; 2019 Jun; 29():102-106. PubMed ID: 31196471
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Opportunity lost: Adjuvant chemotherapy in patients with stage III colon cancer remains underused.
    Becerra AZ; Probst CP; Tejani MA; Aquina CT; González MG; Hensley BJ; Noyes K; Monson JR; Fleming FJ
    Surgery; 2015 Sep; 158(3):692-9. PubMed ID: 26032822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.